Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge

ACS Infect Dis. 2020 Nov 13;6(11):2830-2843. doi: 10.1021/acsinfecdis.0c00353. Epub 2020 Oct 9.

Abstract

Chagas disease is a neglected tropical disease and a global public health issue. In terms of treatment, no progress has been made since the 1960s, when benznidazole and nifurtimox, two obsolete drugs still prescribed, were used to treat this disease. Hence, currently, there are no effective treatments available to tackle Chagas disease. Over the past 20 years, there has been an increasing interest in the disease. However, parasite genetic diversity, drug resistance, tropism, and complex life cycle, along with the limited understanding of the disease and inadequate methodologies and strategies, have resulted in the absence of new insights in drugs development and disappointing outcomes in clinical trials so far. In summary, new drugs are urgently needed. This Review considers the relevant aspects related to the lack of drugs for Chagas disease, resumes the advances in tools for drug discovery, and discusses the main features to be taken into account to develop new effective drugs.

Keywords: American trypanosomiasis; Chagas disease; Trypanosoma cruzi; chemotherapy; drug discovery; neglected tropical disease; screening cascade; target product profile.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Chagas Disease* / drug therapy
  • Drug Discovery
  • Life Cycle Stages
  • Trypanocidal Agents* / therapeutic use
  • Trypanosoma cruzi* / genetics

Substances

  • Trypanocidal Agents